CMR Surgical valuation, funding and investors

CMR Surgical works in surgical robotics solutions development, based in Cambridge, United Kingdom. Founded in 2014, it has about 680 employees.

Medical Supply Manufacturers Growth Equity

VALUATION · TODAY

$3.52B +10% after Growth

Range $2.47B – $5.48B · Grade B

TODAY

+12 MO

$2.00B

$4.00B

$6.00B

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

2026

2027

Series A $46.0M

Series B $100M

Series C $252M

Series D $600M

Growth $165M

Growth $200M

Growth $400M

ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then

HEADCOUNT · TODAY666 employees

+7%6m growth

+5%1y growth

−12%2y growth

500

1,000

1,500

Data from Jan 2021

TODAY

Predicted in 1 yr $3.86B +10% vs today

Predicted next raise $379M if a round comes

Winding-down probability 0%

Last round: Growth · $400M · Oct 2026
Valuation at last round: $3.51B · implied
Headcount: 666 · flat
Grade: B
Founded: 2014

How VCMC values companies →

CMR Surgical valuation today

VCMC values CMR Surgical at $3.5B today, with a range of $2.5B to $5.5B and a grade of B. The valuation starts from its last funding round, a growth round in Oct 2026.

Valuation by date (162 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

CMR Surgical: valuation by date, as the model would have shown it on each date
Date	Valuation	Range	Predicted in 1 yr	Phase	Headcount	Trend	Grade	Winding-down probability
1 Jan 2014	$3.14M	$1.14M – $8.62M	$3.29M (+5%)	before first round	–	unknown	D	0%
1 Feb 2014	$3.15M	$1.15M – $8.65M	$3.30M (+5%)	before first round	–	unknown	D	0%
1 Mar 2014	$3.16M	$1.15M – $8.68M	$3.31M (+5%)	before first round	–	unknown	D	0%
1 Apr 2014	$3.17M	$1.16M – $8.72M	$3.33M (+5%)	before first round	–	unknown	D	0%
1 May 2014	$3.19M	$1.16M – $8.75M	$3.34M (+5%)	before first round	–	unknown	D	0%
1 Jun 2014	$3.20M	$1.16M – $8.79M	$3.35M (+5%)	before first round	–	unknown	D	0%
1 Jul 2014	$3.21M	$1.17M – $8.82M	$3.37M (+5%)	before first round	–	unknown	D	0%
1 Aug 2014	$3.22M	$1.17M – $8.86M	$3.38M (+5%)	before first round	–	unknown	D	0%
1 Sep 2014	$3.24M	$1.18M – $8.89M	$3.39M (+5%)	before first round	–	unknown	D	0%
1 Oct 2014	$3.25M	$1.18M – $8.93M	$3.41M (+5%)	before first round	–	unknown	D	0%
1 Nov 2014	$3.26M	$1.19M – $8.96M	$3.42M (+5%)	before first round	–	unknown	D	0%
1 Dec 2014	$3.28M	$1.19M – $9.00M	$3.43M (+5%)	before first round	–	unknown	D	0%
1 Jan 2015	$3.29M	$1.20M – $9.03M	$3.45M (+5%)	before first round	–	unknown	D	0%
1 Feb 2015	$3.30M	$1.20M – $9.07M	$3.46M (+5%)	before first round	–	unknown	D	0%
1 Mar 2015	$3.31M	$1.21M – $9.10M	$3.47M (+5%)	before first round	–	unknown	D	0%
1 Apr 2015	$3.33M	$1.21M – $9.14M	$3.49M (+5%)	before first round	–	unknown	D	0%
1 May 2015	$3.34M	$1.22M – $9.17M	$3.50M (+5%)	before first round	–	unknown	D	0%
1 Jun 2015	$3.35M	$1.22M – $9.21M	$3.51M (+5%)	before first round	–	unknown	D	0%
1 Jul 2015	$3.37M	$1.23M – $9.24M	$3.53M (+5%)	before first round	–	unknown	D	0%
1 Aug 2015	$3.38M	$1.23M – $9.28M	$3.62M (+7%)	before first round	–	unknown	D	0%
1 Sep 2015	$3.39M	$1.23M – $9.32M	$3.72M (+10%)	before first round	–	unknown	D	0%
1 Oct 2015	$3.41M	$1.24M – $9.35M	$3.81M (+12%)	before first round	–	unknown	D	0%
1 Nov 2015	$3.42M	$1.24M – $9.39M	$3.92M (+15%)	before first round	–	unknown	D	0%
1 Dec 2015	$3.43M	$1.25M – $9.43M	$4.02M (+17%)	before first round	–	unknown	D	0%
1 Jan 2016	$3.45M	$1.25M – $9.47M	$4.13M (+20%)	before first round	–	unknown	D	0%
1 Feb 2016	$3.46M	$1.26M – $9.50M	$4.24M (+23%)	before first round	–	unknown	D	0%
1 Mar 2016	$3.47M	$1.26M – $9.54M	$4.35M (+25%)	before first round	–	unknown	D	0%
1 Apr 2016	$3.49M	$1.27M – $9.58M	$4.47M (+28%)	before first round	–	unknown	D	0%
1 May 2016	$3.50M	$1.27M – $9.61M	$4.59M (+31%)	before first round	–	unknown	D	0%
1 Jun 2016	$3.51M	$1.28M – $9.65M	$4.71M (+34%)	before first round	–	unknown	D	0%
1 Jul 2016	$3.53M	$1.28M – $9.69M	$4.83M (+37%)	before first round	–	unknown	D	0%
1 Aug 2016	$3.62M	$1.32M – $9.95M	$4.96M (+37%)	before first round	–	unknown	D	0%
1 Sep 2016	$3.72M	$1.35M – $10.2M	$5.10M (+37%)	before first round	–	unknown	D	0%
1 Oct 2016	$3.82M	$1.39M – $10.5M	$5.23M (+37%)	before first round	–	unknown	D	0%
1 Nov 2016	$3.92M	$1.43M – $10.8M	$5.38M (+37%)	before first round	–	unknown	D	0%
1 Dec 2016	$4.02M	$1.46M – $11.1M	$5.52M (+37%)	before first round	–	unknown	D	0%
1 Jan 2017	$4.13M	$1.50M – $11.3M	$5.66M (+37%)	before first round	–	unknown	D	0%
1 Feb 2017	$4.24M	$1.54M – $11.7M	$5.82M (+37%)	before first round	–	unknown	D	0%
1 Mar 2017	$4.35M	$1.58M – $11.9M	$5.96M (+37%)	before first round	–	unknown	D	0%
1 Apr 2017	$4.46M	$1.63M – $12.3M	$6.12M (+37%)	before first round	–	unknown	D	0%
1 May 2017	$4.58M	$1.67M – $12.6M	$6.28M (+37%)	before first round	–	unknown	D	0%
1 Jun 2017	$4.71M	$1.71M – $12.9M	$6.45M (+37%)	before first round	–	unknown	D	0%
1 Jul 2017	$4.83M	$1.76M – $13.3M	$6.62M (+37%)	before first round	–	unknown	D	0%
1 Aug 2017	$4.96M	$1.81M – $13.6M	$6.80M (+37%)	before first round	–	unknown	D	0%
1 Sep 2017	$5.10M	$1.85M – $14.0M	$6.99M (+37%)	before first round	–	unknown	D	0%
19 Sep 2017	$235M	$154M – $642M	$422M (+80%)	after a round	–	unknown	C	0%
1 Oct 2017	$239M	$154M – $642M	$422M (+76%)	after a round	–	unknown	C	0%
1 Nov 2017	$252M	$154M – $642M	$422M (+68%)	after a round	–	unknown	C	0%
1 Dec 2017	$264M	$154M – $642M	$422M (+60%)	after a round	–	unknown	C	0%
1 Jan 2018	$278M	$154M – $642M	$422M (+52%)	after a round	–	unknown	C	0%
1 Feb 2018	$292M	$154M – $642M	$422M (+45%)	after a round	–	unknown	C	0%
1 Mar 2018	$305M	$154M – $642M	$422M (+38%)	after a round	–	unknown	C	0%
1 Apr 2018	$321M	$154M – $642M	$422M (+32%)	after a round	–	unknown	C	0%
1 May 2018	$337M	$154M – $642M	$422M (+25%)	after a round	–	unknown	C	0%
1 Jun 2018	$354M	$154M – $642M	$422M (+19%)	after a round	–	unknown	C	0%
1 Jul 2018	$371M	$154M – $642M	$422M (+14%)	after a round	–	unknown	C	0%
1 Aug 2018	$390M	$154M – $642M	$422M (+8%)	after a round	–	unknown	C	0%
1 Sep 2018	$410M	$154M – $642M	$422M (+3%)	after a round	–	unknown	C	0%
1 Oct 2018	$422M	$151M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Nov 2018	$422M	$143M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Dec 2018	$422M	$136M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Jan 2019	$422M	$130M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Feb 2019	$422M	$123M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Mar 2019	$422M	$118M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Apr 2019	$422M	$112M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 May 2019	$422M	$106M – $642M	$422M (0%)	after a round	–	unknown	C	0%
1 Jun 2019	$422M	$101M – $642M	$422M (0%)	after a round	–	unknown	C	0%
22 Jun 2019	$599M	$421M – $1.3B	$897M (+50%)	after a round	–	unknown	B	0%
1 Jul 2019	$605M	$421M – $1.3B	$897M (+48%)	after a round	–	unknown	B	0%
1 Aug 2019	$626M	$421M – $1.3B	$897M (+43%)	after a round	–	unknown	B	0%
1 Sep 2019	$648M	$421M – $1.3B	$897M (+38%)	after a round	–	unknown	B	0%
1 Oct 2019	$670M	$421M – $1.3B	$897M (+34%)	after a round	–	unknown	B	0%
1 Nov 2019	$693M	$421M – $1.3B	$897M (+29%)	after a round	–	unknown	B	0%
1 Dec 2019	$717M	$421M – $1.3B	$897M (+25%)	after a round	–	unknown	B	0%
3 Dec 2019	$1.5B	$1.0B – $2.7B	$1.9B (+30%)	after a round	–	unknown	B	0%
1 Jan 2020	$1.5B	$1.0B – $2.7B	$1.9B (+27%)	after a round	–	unknown	B	0%
1 Feb 2020	$1.5B	$1.0B – $2.7B	$1.9B (+24%)	after a round	–	unknown	B	0%
1 Mar 2020	$1.6B	$1.0B – $2.7B	$1.9B (+22%)	after a round	–	unknown	B	0%
1 Apr 2020	$1.6B	$1.0B – $2.7B	$1.9B (+19%)	after a round	–	unknown	B	0%
1 May 2020	$1.6B	$1.0B – $2.7B	$1.9B (+17%)	after a round	–	unknown	B	0%
1 Jun 2020	$1.7B	$1.0B – $2.7B	$1.9B (+14%)	after a round	–	unknown	B	0%
1 Jul 2020	$1.7B	$1.0B – $2.7B	$1.9B (+12%)	after a round	–	unknown	B	0%
1 Aug 2020	$1.7B	$1.0B – $2.7B	$1.9B (+9%)	after a round	–	unknown	B	0%
1 Sep 2020	$1.8B	$1.0B – $2.7B	$1.9B (+7%)	after a round	–	unknown	B	0%
1 Oct 2020	$1.8B	$1.0B – $2.7B	$1.9B (+4%)	after a round	–	unknown	B	0%
1 Nov 2020	$1.9B	$1.0B – $2.7B	$1.9B (+2%)	after a round	–	unknown	B	0%
1 Dec 2020	$1.9B	$1.0B – $2.7B	$1.9B (0%)	after a round	–	unknown	B	0%
1 Jan 2021	$1.9B	$985M – $2.7B	$1.9B (0%)	after a round	440	unknown	B	0%
1 Feb 2021	$1.9B	$940M – $2.7B	$1.9B (0%)	after a round	440	unknown	B	0%
1 Mar 2021	$1.9B	$902M – $2.7B	$1.9B (0%)	after a round	440	unknown	B	0%
1 Apr 2021	$1.9B	$861M – $2.7B	$1.9B (0%)	after a round	440	flat	B	0%
1 May 2021	$1.9B	$823M – $2.7B	$1.9B (0%)	after a round	440	flat	B	0%
1 Jun 2021	$1.9B	$786M – $2.7B	$1.9B (0%)	after a round	440	flat	C	0%
29 Jun 2021	$3.0B	$2.6B – $4.5B	$3.9B (+30%)	after a round	440	flat	A	0%
1 Jul 2021	$3.0B	$2.6B – $4.5B	$3.9B (+30%)	after a round	440	flat	A	0%
1 Aug 2021	$3.1B	$2.6B – $4.5B	$3.9B (+27%)	after a round	440	flat	A	0%
1 Sep 2021	$3.1B	$2.6B – $4.5B	$3.9B (+24%)	after a round	440	flat	A	0%
1 Oct 2021	$3.2B	$2.6B – $4.5B	$3.9B (+21%)	after a round	440	flat	A	0%
1 Nov 2021	$3.3B	$2.6B – $4.5B	$3.9B (+19%)	after a round	440	flat	A	0%
1 Dec 2021	$3.4B	$2.6B – $4.5B	$3.9B (+16%)	after a round	440	flat	A	0%
1 Jan 2022	$3.4B	$2.6B – $4.5B	$3.9B (+14%)	after a round	440	flat	A	0%
1 Feb 2022	$3.5B	$2.6B – $4.5B	$3.9B (+11%)	after a round	440	flat	A	0%
1 Mar 2022	$3.9B	$2.6B – $5.0B	$4.4B (+13%)	after a round	730	growing	B	0%
1 Apr 2022	$4.0B	$2.6B – $5.0B	$4.4B (+9%)	after a round	730	growing	B	0%
1 May 2022	$4.1B	$2.6B – $5.0B	$4.4B (+6%)	after a round	730	growing	B	0%
1 Jun 2022	$4.2B	$2.6B – $5.0B	$4.4B (+3%)	after a round	730	growing	B	0%
1 Jul 2022	$4.4B	$2.6B – $5.0B	$4.4B (0%)	after a round	730	growing	B	0%
1 Aug 2022	$4.4B	$2.7B – $5.0B	$4.4B (0%)	after a round	730	growing	B	0%
1 Sep 2022	$4.4B	$2.7B – $5.0B	$4.4B (0%)	after a round	730	growing	B	0%
1 Oct 2022	$4.4B	$2.7B – $5.0B	$4.4B (0%)	after a round	730	growing	B	0%
1 Nov 2022	$4.4B	$2.2B – $5.0B	$4.4B (0%)	after a round	730	unknown	B	0%
1 Dec 2022	$4.4B	$2.2B – $5.0B	$4.4B (0%)	after a round	730	unknown	B	0%
1 Jan 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Feb 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Mar 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Apr 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 May 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Jun 2023	$4.6B	$2.7B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Jul 2023	$4.6B	$2.5B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Aug 2023	$4.6B	$2.4B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
1 Sep 2023	$4.6B	$2.4B – $5.3B	$4.6B (0%)	after a round	930	up	B	0%
21 Sep 2023	$1.7B	$1.1B – $2.8B	$1.9B (+10%)	after a round	930	unknown	B	0%
1 Oct 2023	$1.7B	$1.1B – $2.6B	$1.7B (0%)	after a round	780	down	B	88%
1 Nov 2023	$1.7B	$1.1B – $2.6B	$1.6B (-3%)	after a round	780	down	B	88%
1 Dec 2023	$1.7B	$1.1B – $2.6B	$1.6B (-5%)	after a round	780	down	B	88%
1 Jan 2024	$1.7B	$1.1B – $2.6B	$1.6B (-8%)	after a round	780	down	B	88%
1 Feb 2024	$1.7B	$1.1B – $2.5B	$1.5B (-12%)	after a round	750	down	B	97%
1 Mar 2024	$1.7B	$1.1B – $2.6B	$1.4B (-14%)	after a round	760	down	B	97%
1 Apr 2024	$1.7B	$1.1B – $2.6B	$1.4B (-17%)	after a round	760	down	B	97%
1 May 2024	$1.7B	$1.1B – $2.6B	$1.4B (-19%)	after a round	760	down	B	97%
1 Jun 2024	$1.7B	$1.1B – $2.6B	$1.3B (-21%)	after a round	760	down	B	97%
1 Jul 2024	$1.7B	$1.1B – $2.6B	$1.3B (-24%)	after a round	760	down	B	97%
1 Aug 2024	$1.7B	$1.1B – $2.6B	$1.3B (-24%)	after a round	760	flat	B	89%
1 Sep 2024	$1.7B	$1.1B – $2.6B	$1.3B (-24%)	after a round	760	flat	B	82%
1 Oct 2024	$1.7B	$1.1B – $2.6B	$1.3B (-26%)	after a round	760	flat	B	76%
1 Nov 2024	$1.7B	$1.0B – $2.6B	$1.3B (-24%)	after a round	740	flat	B	70%
1 Dec 2024	$1.6B	$969M – $2.6B	$1.3B (-23%)	after a round	740	flat	B	64%
1 Jan 2025	$1.6B	$921M – $2.7B	$1.3B (-21%)	after a round	740	flat	B	59%
1 Feb 2025	$1.6B	$875M – $2.7B	$1.3B (-20%)	after a round	740	flat	B	54%
1 Mar 2025	$1.6B	$836M – $2.7B	$1.3B (-18%)	after a round	740	flat	B	50%
1 Apr 2025	$1.6B	$795M – $2.7B	$1.3B (-17%)	after a round	740	flat	C	46%
3 Apr 2025	$2.0B	$1.4B – $3.1B	$2.2B (+9%)	after a round	740	flat	B	7%
1 May 2025	$2.0B	$1.4B – $3.1B	$2.2B (+8%)	after a round	740	flat	B	7%
1 Jun 2025	$2.0B	$1.4B – $3.1B	$2.2B (+7%)	after a round	740	flat	B	7%
1 Jul 2025	$2.0B	$1.4B – $3.1B	$2.2B (+6%)	after a round	740	flat	B	7%
1 Aug 2025	$2.0B	$1.4B – $2.9B	$1.8B (-9%)	after a round	634	down	B	85%
1 Sep 2025	$2.0B	$1.4B – $2.8B	$1.7B (-13%)	after a round	634	down	B	96%
1 Oct 2025	$2.0B	$1.4B – $2.8B	$1.7B (-15%)	after a round	634	down	B	94%
1 Nov 2025	$2.0B	$1.4B – $2.8B	$1.6B (-18%)	after a round	622	down	B	97%
1 Dec 2025	$2.0B	$1.4B – $2.8B	$1.6B (-20%)	after a round	622	down	B	97%
1 Jan 2026	$2.0B	$1.4B – $2.8B	$1.5B (-23%)	after a round	622	down	B	97%
1 Feb 2026	$2.0B	$1.4B – $2.8B	$1.5B (-25%)	after a round	622	down	B	97%
1 Mar 2026	$2.0B	$1.4B – $2.8B	$1.5B (-25%)	after a round	622	down	B	91%
1 Apr 2026	$2.0B	$1.4B – $2.8B	$1.4B (-28%)	after a round	622	down	B	91%
1 May 2026	$2.0B	$1.3B – $2.9B	$1.4B (-28%)	after a round	655	down	B	83%
1 Jun 2026	$2.0B	$1.3B – $2.9B	$1.4B (-26%)	after a round	655	flat	B	77%
1 Jul 2026	$1.9B	$1.2B – $2.9B	$1.5B (-25%)	after a round	655	flat	B	71%
1 Aug 2026	$1.9B	$1.2B – $3.0B	$1.5B (-23%)	after a round	655	flat	B	65%
1 Sep 2026	$1.9B	$1.1B – $3.0B	$1.5B (-22%)	after a round	655	flat	B	60%
1 Oct 2026	$1.9B	$1.0B – $3.0B	$1.5B (-20%)	after a round	666	flat	B	55%
13 Oct 2026	$3.5B	$2.5B – $5.5B	$3.9B (+10%)	after a round	666	flat	B	0%
24 Oct 2026	$3.5B	$2.5B – $5.5B	$3.9B (+10%)	after a round	666	flat	B	0%

Key facts about CMR Surgical

Founded: 2014
Headquarters: Cambridge, United Kingdom
Employees: about 680 +7% in a year
Total raised: $1.76B
Funding rounds: 7
Last round: Growth Equity Oct 2026

CMR Surgical was founded in 2014 by Keith Marshall, Luke Hares, Mark Slack, Martin Frost and Paul Roberts.

CMR Surgical funding history

CMR Surgical has 7 funding rounds on record, from Sep 2017 to Oct 2026, $1.76B in total. The latest disclosed valuation is $3.00B post-money (Series D, Jun 2021).

Growth Equity 12 Oct 2026
Led by Stryker Corporation.
Sources: globenewswire.com, precedenceresearch.com, investors.stryker.com and 5 more
$400M
Growth Equity 2 Apr 2025
With Trinity Capital, SoftBank, Lightrock, Ally Bridge, existing major investors.
Sources: globenewswire.com, cic.vc, nhsprocurement.org.uk and 7 more
$200M
Growth Equity 20 Sep 2023
With Ally Bridge Group, Cambridge Innovation Capital, Escala Capital, LGT Capital Partners, Lightrock, RPMI Railpen, SoftBank Vision Fund, Tencent, Watrium, SoftBank.
Sources: medtechdive.com, fiercebiotech.com, uk.finance.yahoo.com and 2 more
$165M
Series D 28 Jun 2021
Led by SoftBank Vision Fund, Ally Bridge Group; with RPMI Railpen, Tencent, Chimera VC, LGT Capital Partners, Lightrock, Watrium, Cambridge Innovation Capital, PFM Health Sciences, GE Healthcare, Escala Capital, ABB Technology Ventures.
Sources: globenewswire.com, uk.finance.yahoo.com, cambridgenetwork.co.uk and 5 more
$600M
$3.00B post-money
Series C 2 Dec 2019
With Cambridge Innovation Capital.
Sources: globenewswire.com, enterprise.cam.ac.uk, globenewswire.com
$252M
Series B 21 Jun 2019
Investors not disclosed.
Sources: globenewswire.com, globenewswire.com
$100M
Series A 18 Sep 2017
With ABB Technology Ventures, Cambridge Innovation Capital, Escala Capital, LGT Capital Partners, Watrium.
Sources: biospace.com
$46M

CMR Surgical investors

18 investors have backed CMR Surgical; Ally Bridge Group, SoftBank Vision Fund and Stryker Corporation led at least one round.

SoftBank Vision Fund lead, 2 rounds
Stryker Corporation lead
Escala Capital 3 rounds
Lightrock 3 rounds
ABB Technology Ventures 2 rounds
RPMI Railpen 2 rounds
SoftBank 2 rounds
Tencent 2 rounds
Ally Bridge
existing major investors
GE Healthcare
PFM Health Sciences

What CMR Surgical does

CMR Surgical works in medical supply manufacturers, with 14 recorded offerings and customers in healthcare.

CMR Surgical Ltd is a British private limited company engaged in the development, manufacturing, and distribution of surgical robotics systems for minimal access surgery. The company provides surgical robots, digital ecosystems for data analysis and operational efficiency, and training programs for healthcare professionals. CMR Surgical also conducts research and development, participates in clinical studies, and collaborates with healthcare institutions. Its operations serve hospitals and surgeons internationally, with a focus on regulatory compliance and global market presence.

Description from Veridion's company data.

Products and services

Surgical Robotics Solutions Development
Modular Surgical Robot Manufacturing
Portable Surgical Robot Manufacturing
Digital Surgical Ecosystem Development
Surgical Robotics Regulatory Compliance Services
Clinical Adoption Support Services
Surgical Robotics Training Services
Surgical Robotics Research and Development
Clinical Study Execution Services
Surgical Data Analytics Solutions
Patient Outcome Improvement Services
Operational Efficiency Enhancement Services
Global Surgical Robotics Distribution
Surgical Robotics Partnership Services

Markets

Healthcare

Technology

Surgical Robotics Systems

Certifications

FDA certified
FCC certified

Business model

Business-to-Business
Manufacturing

Industry codes (NAICS)

339112 Surgical and Medical Instrument Manufacturing 60% match
541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) 25% match
611430 Professional and Management Development Training 15% match

Questions about CMR Surgical

What is CMR Surgical worth?

Valuation $3.5B (range $2.5B to $5.5B), as of 24 Oct 2026. The last disclosed valuation was $3.00B (Series D, Jun 2021).

Has CMR Surgical raised money?

CMR Surgical has 7 funding rounds on record, from Sep 2017 to Oct 2026, $1.76B in total. The latest disclosed valuation is $3.00B post-money (Series D, Jun 2021).

Who has invested in CMR Surgical?

Ally Bridge Group, SoftBank Vision Fund, Stryker Corporation, Cambridge Innovation Capital, Escala Capital and LGT Capital Partners, and 12 more. Lead investors include Ally Bridge Group, SoftBank Vision Fund and Stryker Corporation.

How many people work at CMR Surgical?

About 680, up 7% over the last year. Headcount rose from 440 in Jan 2021 to 930 in Jan 2023, then fell to 666 in Sep 2026.

What does CMR Surgical do?

CMR Surgical works in medical supply manufacturers, with 14 recorded offerings and customers in healthcare. Its main offerings are surgical robotics solutions development, modular surgical robot manufacturing and portable surgical robot manufacturing.

When was CMR Surgical founded, and where is it based?

CMR Surgical was founded in 2014 and is based in Cambridge, United Kingdom. It has about 680 employees, up 7% over the last year.

How we value companies Report an issue

CMR Surgical valuation, funding and investors

CMR Surgical valuation today

Key facts about CMR Surgical

CMR Surgical funding history

Growth Equity 12 Oct 2026

Growth Equity 2 Apr 2025

Growth Equity 20 Sep 2023

Series D 28 Jun 2021

Series C 2 Dec 2019

Series B 21 Jun 2019

Series A 18 Sep 2017